Tech Company Financing Transactions
RenalGuard Solutions Funding Round
RenalGuard Solutions closed a $14.5 million Series A funding round on 3/17/2017. Backers included Exigent Alternative Capital and Genesis Capital Advisors.
Transaction Overview
Company Name
Announced On
3/17/2017
Transaction Type
Venture Equity
Amount
$14,500,000
Round
Series A
Investors
Exigent Alternative Capital (Lead Investor) (Alan Adler)
Proceeds Purpose
These funds will also further our marketing and sales activities for RenalGuard Therapy in Europe and other regions where the technology is already available for use.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
459 Fortune Blvd.
Milford, MA 01757
USA
Milford, MA 01757
USA
Phone
Website
Email Address
Overview
RenalGuard is a closed loop system designed to minimize the risk of over- or under-hydration while maintaining the high urine flows recommended for the prevention of CIN.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Alex Martin
Chief Executive Officer
James Dillon
Chief Technical Officer
Andrew Halpert
VP - Bus. Development
Gregory Mann
VP - Operations
Kenneth Luppi
Browse more venture capital transactions:
Prev: 3/17/2017: Cnex Labs venture capital transaction
Next: 3/17/2017: Countable venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs